Literature DB >> 10843873

Inhaled NO reduces leukocyte-endothelial cell interactions and myocardial dysfunction in endotoxemic rats.

R Nevière1, B Guery, S Mordon, F Zerimech, S Charré, F Wattel, C Chopin.   

Abstract

Inhaled nitric oxide (NO) has been shown to have some protective effect in the peripheral distal inflamed vasculature. The objective of the study was to determine whether inhaled NO would reduce endotoxin-induced leukocyte activation and myocardial contractile dysfunction. Rats were treated with either saline or endotoxin (10 mg/kg iv) and then allowed to breathe (4 h) either air or air plus NO (10 ppm). In endotoxemic rats, mesenteric venular endothelium leukocyte firm adhesion increased compared with control rats (1.15 +/- 0.32 vs. 4.08 +/- 0.96 leukocytes/100 microm; P < 0.05). Inhaled NO significantly attenuated endotoxin-induced venular endothelium leukocyte adhesion (4.08 +/- 0.96 vs. 1.86 +/- 0.76 leukocytes/100 microm; P < 0.05) and FITC-conjugated anti-intercellular adhesion molecule-1 fluorescence intensity. Endotoxin-induced myocardial dysfunction and leukocyte content increases were reduced in inhaled NO-treated rats. These observations suggest that inhaled NO reduces the degree of cardiovascular dysfunction and inflammation in endotoxemic rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843873     DOI: 10.1152/ajpheart.2000.278.6.H1783

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

1.  Plasma detection of NO by a catheter.

Authors:  Masami Goto; Seiichi Mochizuki
Journal:  Med Biol Eng Comput       Date:  2008-05       Impact factor: 2.602

Review 2.  Extrapulmonary effects of inhaled nitric oxide: role of reversible S-nitrosylation of erythrocytic hemoglobin.

Authors:  Timothy J McMahon; Allan Doctor
Journal:  Proc Am Thorac Soc       Date:  2006-04

3.  Inhaled nitric oxide therapy increases blood nitrite, nitrate, and s-nitrosohemoglobin concentrations in infants with pulmonary hypertension.

Authors:  Yomna I Ibrahim; Janet R Ninnis; Andrew O Hopper; Douglas D Deming; Amy X Zhang; Jason L Herring; Lawrence C Sowers; Timothy J McMahon; Gordon G Power; Arlin B Blood
Journal:  J Pediatr       Date:  2011-09-09       Impact factor: 4.406

4.  Catalytic consumption of nitric oxide by 12/15- lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation.

Authors:  M J Coffey; R Natarajan; P H Chumley; B Coles; P R Thimmalapura; M Nowell; H Kühn; M J Lewis; B A Freeman; V B O'Donnell
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

5.  S-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia.

Authors:  A Jakubowski; N Maksimovich; R Olszanecki; A Gebska; H Gasser; B K Podesser; S Hallström; S Chlopicki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

6.  Intravenous loading of nitroglycerin during rewarming of cardiopulmonary bypass improves metabolic homeostasis in cardiac surgery: a retrospective analysis.

Authors:  Ying-Hsuan Tai; Kuang-Yi Chang; Shu-Wei Liao; Kwei-Chun Chung; Chun-Che Shih; Shung-Tai Ho; Chih-Cherng Lu; Mei-Yung Tsou
Journal:  J Anesth       Date:  2016-06-22       Impact factor: 2.078

Review 7.  Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials.

Authors:  Stephen Trzeciak; Ismail Cinel; R Phillip Dellinger; Nathan I Shapiro; Ryan C Arnold; Joseph E Parrillo; Steven M Hollenberg
Journal:  Acad Emerg Med       Date:  2008-05       Impact factor: 3.451

8.  Elevated cardiac troponins in setting of systemic inflammatory response syndrome, sepsis, and septic shock.

Authors:  Nasir Hussain
Journal:  ISRN Cardiol       Date:  2013-04-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.